脉络宁注射液联合贝那普利治疗慢性肾小球肾炎临床观察

发布时间：2018-04-14 20:10

本文选题：脉络宁注射液 + 贝那普利　；参考：《中华中医药学刊》2017年11期

【摘要】：目的:探索脉络宁注射液联合贝那普利治疗慢性肾小球肾炎(CGN)的临床疗效及用药安全性。方法:从2015年8月—2016年8月期间经医院检查确诊的慢性肾小球肾炎患者中随机选择140例纳入临床研究,按照就诊时间编号并将患者分为观察组和对照组两组,各70例。对照组患者单用贝那普利片治疗,观察组患者给予脉络宁注射液联合贝那普片治疗,观察临床治疗效果及不良反应的发生情况,并进行对比分析。结果:观察组治疗总有效率为91.43%,对照组治疗总有效率为72.86%,经分析两组患者治疗总有效率差异有统计学意义(P0.05)。两组患者治疗前肾功能指标即24 h尿蛋白定量、血肌酐、血尿素氮、血浆白蛋白水平比较,差异无统计学意义(P0.05)。而治疗后上述指标均较治疗前明显改善,且两组比较差异有统计学意义(P0.05)。观察组患者不良反应发生率为5.71%,对照组患者不良反应发生率为8.57%。两组所发生不良反应均属轻微,未经特殊处理自行缓解或消失。两组不良反应发生率比较差异无统计学意义(P0.05)。结论:脉络宁注射液联合贝那普利治疗慢性肾小球肾炎疗效确切,可有效改善患者肾脏功能,且不良反应较少,用药安全性高,值得推广、应用。
[Abstract]:Objective: to investigate the efficacy and safety of Mailuoning injection combined with benazepril in the treatment of chronic glomerulonephritis (CGNN).Methods: 140 patients with chronic glomerulonephritis diagnosed by hospital examination from August 2015 to August 2016 were randomly selected to be included in the clinical study. According to the number of patients, they were divided into two groups: observation group and control group, 70 cases in each group.The patients in the control group were treated with benazepril alone and the patients in the observation group were treated with Mailuoning injection combined with benapril tablet.Results: the total effective rate of treatment was 91.43 in the observation group and 72.86 in the control group. The difference of the total effective rate between the two groups was statistically significant (P 0.05).There was no significant difference between the two groups in terms of 24 h urinary protein quantity, serum creatinine, blood urea nitrogen and plasma albumin levels before treatment (P 0.05).The above indexes were significantly improved after treatment, and the difference between the two groups was statistically significant (P 0.05).The incidence of adverse reactions was 5.71 in the observation group and 8.57 in the control group.The adverse reactions in both groups were mild and relieved or disappeared without special treatment.There was no significant difference in the incidence of adverse reactions between the two groups (P 0.05).Conclusion: Mailuoning injection combined with benazepril is effective in the treatment of chronic glomerulonephritis.
【作者单位】：黄冈市中心医院;浙江省立同德医院肾内科;
【基金】：浙江省中医药科技计划项目(2013ZA034)
【分类号】：R692.31

【相似文献】